1. "Melanoma and Immunotherapeutics Service"
Formats
  1. Journal Article (954)
  2. Meeting Abstract (771)
  3. Book Section (42)
  4. Editorial (32)
  5. Review (26)
  6. Research Letter (15)
  7. Guidelines (6)
  8. Correspondence (5)
  9. Conference Paper (4)
  10. Miscellaneous (3)
  11. Book Whole (2)
Groups
  1. Department of Medicine (1860)
  2. Melanoma and Immunotherapeutics Service (1860)
  3. Solid Tumor Oncology Division (1860)
  4. GSK Faculty (1050)
  5. Melanoma Disease Management Team (782)
  6. Hematologic Malignancies, Division of (507)

More Groups

People
  1. Jedd Wolchok (905)
  2. Taha Merghoub (364)
  3. Michael Postow (361)
  4. Paul Chapman (326)
  5. Alexander Shoushtari (244)
  6. Margaret Callahan (197)

More People

Years
  1. 2025 (22)
  2. 2024 (46)
  3. 2023 (66)
  4. 2022 (125)
  5. 2021 (112)
  6. 2020 (122)

More Years

Publications
  1. Journal of Clinical Oncology (330)
  2. Journal for ImmunoTherapy of Cancer (131)
  3. Cancer Research (106)
  4. Clinical Cancer Research (90)
  5. Annals of Oncology (77)
  6. Proceedings of the American Association for Cancer Research Annual Meeting (43)

More Publications

Publishers
  1. American Society of Clinical Oncology (342)
  2. American Association for Cancer Research (274)
  3. Biomed Central Ltd (148)
  4. Elsevier Inc. (144)
  5. Oxford University Press (109)
  6. Nature Publishing Group (88)

More Publishers

Results (1860)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Concurrent radiation therapy (RT), ipilimumab (ipi) and/or nivolumab (nivo) on a phase 1 clinical trial
    Meeting Abstract

    Barker, C. A.; Postow, M. A.; Kronenberg, S. A.; Ma, J.; Yamada, Y.; Beal, K.; Chan, T. A.; Callahan, M. K.; Wolchok, J. D.
    International Journal of Radiation Oncology, Biology, Physics (2015)

    Fulltext@MSK | Save
  • Requirement for innate immunity and CD90(+)NK1.1(-) lymphocytes to treat established melanoma with chemo-immunotherapy
    Journal Article

    Moskalenko, M.; Pan, M.; Fu, Y.; De Moll, E. H.; Hashimoto, D.; Mortha, A.; Leboeuf, M.; Jayaraman, P.; Bernardo, S.; Sikora, A. G.; more...
    Cancer Immunology Research (2015)

    Fulltext@MSK | Save
  • Combination immunotherapy for melanoma
    Meeting Abstract

    Wolchok, J. D.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Immunomodulatory activity of nivolumab monotherapy in patients with advanced melanoma
    Meeting Abstract

    Urba, W. J.; Martin-Algarra, S.; Callahan, M.; Wolchok, J. D.; Sharfman, W. H.; Sosman, J. A.; Bhatia, S.; Hwu, W. J.; Gajewski, T. F.; Slingluff, C. L.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Improved clinical response in patients with advanced melanoma treated with nivolumab combined with ipilimumab compared to ipilimumab alone
    Meeting Abstract

    Hodi, F. S.; Postow, M. A.; Chesney, J.; Pavlick, A. C.; Robert, C.; Grossmann, K.; McDermott, D.; Linette, G.; Meyer, N.; Giguere, J.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • CCR 20th Anniversary commentary: Immune-related response criteria - Capturing clinical activity in immuno-oncology
    Journal Article

    Hoos, A.; Wolchok, J. D.; Humphrey, R. W.; Hodi, F. S.
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save
  • Multiple gastrointestinal polyps in patients treated with BRAF inhibitors
    Journal Article

    Amaravadi, R. K.; Hamilton, K. E.; Ma, X.; Piao, S.; Del Portillo, A.; Nathanson, K. L.; Carlino, M. S.; Long, G. V.; Puzanov, I.; Xu, X.; more...
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save
  • The new era of cancer immunotherapy: Manipulating T-cell activity to overcome malignancy
    Journal Article

    Khalil, D. N.; Budhu, S.; Gasmi, B.; Zappasodi, R.; Hirschhorn-Cymerman, D.; Plitt, T.; De Henau, O.; Zamarin, D.; Holmgaard, R. B.; Murphy, J. T.; more...
    Advances in Cancer Research (2015)

    Fulltext@MSK | Save
  • Efficacy and safety in key patient subgroups of vivolumab (NIVO) alone or combined with ipilimumab (IPI) versus IPI alone in treatment-naive patients with advanced melanoma (MEL) (Checkmate 067)
    Meeting Abstract

    Larkin, J.; Chiarion-Sileni, V.; Gonzalez, R.; Grob, J. J.; Cowey, C. L.; Lao, C. D.; Wagstaff, J.; Hogg, D.; Hill, A.; Carlino, M. S.; more...
    Asia-Pacific Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Clinical response, progression-free survival (PFS) and safety in patients (pts) with advanced melanoma (MEL) receiving nivolumab (NIVO) combined with ipilimumab (IPI) versus IPI monotherapy in Checkmate 069 study
    Meeting Abstract

    Hodi, F. S.; Postow, M. A.; Chesney, J.; Pavlik, A. C.; Robert, C.; Grossman, K.; McDermott, D.; Linette, G.; Meyer, N.; Giguere, J. K.; more...
    Asia-Pacific Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save